{
    "title": "Roche immunotherapy Tecentriq gains European approval for breast cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7405857/Roche-immunotherapy-Tecentriq-gains-European-approval-breast-cancer.html",
    "date": "2019-08-29",
    "keywords": [
        "cancer",
        "breast",
        "tecentriq",
        "approval",
        "use",
        "roche",
        "market",
        "treatment",
        "toughtotreat",
        "drugmaker",
        "immunotherapy",
        "revenue",
        "commission",
        "abraxane",
        "protein",
        "attack",
        "bodys",
        "immune",
        "system",
        "merck",
        "niche",
        "meaning",
        "combination",
        "step",
        "need",
        "officer",
        "sandra",
        "horning",
        "statement",
        "track",
        "year",
        "opdivo",
        "keytruda",
        "head",
        "start",
        "reporting",
        "john",
        "miller",
        "editing",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}